Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
about
Long term hormone therapy for perimenopausal and postmenopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Long-term hormone therapy for perimenopausal and postmenopausal women.Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis.Menstrual cycle-related exacerbation of diseaseOccult breast tumor reservoir: biological properties and clinical significance.Ductal carcinoma in situ of the breast: a surgical perspective.Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.The 2012 hormone therapy position statement of: The North American Menopause Society.Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know?Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.IMS updated recommendations on postmenopausal hormone therapy.The Mammary Glands of MacaquesHormone therapy and fatal breast cancer.A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsOspemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomizationMemory Impairment in Estrogen Receptor α Knockout Mice Through Accumulation of Amyloid-β Peptides.Impact of risk-reducing salpingo-oophorectomy in premenopausal women.Is HRT justified for symptom management in women at higher risk of developing breast cancer?Current breast cancer risks of hormone replacement therapy in postmenopausal women.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectiveNew-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.Hormone therapy and breast cancer risk.Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureEstrogen plus progestin therapy and breast cancer in recently postmenopausal women.Postmenopausal hormone therapy and cardiovascular disease in perspective.The tissue selective estrogen complex: a promising new menopausal therapyEstrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.Is there evidence that estrogen therapy promotes weight maintenance via effects on leptin?Sex hormones and lipoprotein(a) concentration.HRT in difficult circumstances: are there any absolute contraindications?Hormone replacement therapy and the risk of breast cancer.Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.Postmenopausal hormone therapy: risks and benefits.
P2860
Q24201974-FB9941C4-A9AB-45B5-BB06-4D15ADD1EC10Q24658109-C52CDA57-7B85-4E44-B92C-7D09AE6BC2BAQ30238978-92B7F654-BDEE-4B3B-8A02-44AD242A5EA3Q30239742-8ECF4C1C-1FDC-4BDA-A1E9-C9988B803AB3Q30431992-6D44B978-F254-4EBF-946A-EC1135D46EFEQ30456637-7ABC1D8D-0CA6-4882-88D6-66A7FA2411AFQ30463534-25147BCA-E983-4329-812B-BD99B0FDA687Q30474007-AA31E36C-DE2C-4DF3-92E7-CEEDE34C86FFQ34161400-0938F7A2-7833-45EC-941C-AA97128EF418Q34285969-F0E6FF37-B72B-4805-B9A2-59F12112F2CDQ34490225-2037657C-3025-4400-B370-85B145BC8F71Q34626471-CF90E00C-6FB7-46A1-B946-005E324636BCQ34762947-B2193BFE-9BC3-4A9B-AC83-005BFCFB17C1Q34994476-F58ADABF-4210-4274-9869-B225E5DCA446Q35035445-45F080F5-A5C7-4338-9C17-EC58935A739DQ35092002-37C8D35A-2C84-48EC-A6D1-0C67E8096868Q35634204-8C8052B8-97E6-4D56-B8C5-3CD89DCCC27CQ35657905-A6A4FB87-80D7-4265-82CF-A633E94DD5DCQ35859830-C0B6B1E1-641F-45B7-9F41-1EB32E178847Q35878258-1B6D2D7C-3A69-4035-B31F-01FE8DA1A6BAQ36372962-49C7698D-9D0B-4FEE-BAAE-DAC618919428Q36645276-E765CC0C-2942-4B78-8D23-070EC106F3A4Q36675379-89589678-FCB3-43DE-8862-DB649E00F17BQ36781520-3109E55A-1BCE-42D2-93E1-3E0BC3F6117BQ36896822-E189F326-CD0D-480A-AB2E-8462E9B08260Q36939490-F024B96A-D3B1-433A-9918-62294EEE01C0Q36946798-EF851009-65FF-4CC8-9003-96663600E0A6Q36970351-5884B800-BFC3-464D-9935-E7C7A60DCDEAQ37014593-7C1075C9-FEDD-48E0-BC42-51A6C394743DQ37048294-26D19475-A895-4068-BB82-51830ABFD471Q37163009-829C20B2-C07B-4D42-87BA-1909E519D6D3Q37234323-90A51290-05C0-49D7-9DD2-807DDCCE03FBQ37277298-BA7249C2-5FDE-4C83-B83E-62C4E423578FQ37480990-855649AC-34F8-402B-A73C-360DC7AB4203Q37669667-AA0CA462-EE4A-4444-A4A0-7EB31DF2285CQ37825893-8B10BFCF-1C62-4161-ADD0-2FB80A5077BAQ37847568-EBD2480D-28A6-458D-82AA-0676C15E1B79Q37909897-85554F4C-E94F-4415-BBB1-875EB5B18F04Q37989179-B4037916-61CC-4D31-894D-6418AAC49AE7Q38082563-A882F6E2-94AD-4794-B7F9-C832746AFEE4
P2860
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@ast
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@en
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@nl
type
label
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@ast
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@en
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@nl
prefLabel
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@ast
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@en
Prior hormone therapy and brea ...... al of estrogen plus progestin.
@nl
P2093
P50
P1433
P1476
Prior hormone therapy and brea ...... ial of estrogen plus progestin
@en
P2093
Anita Aggerwal
Anne McTiernan
Dorothy S Lane
F Allan Hubbell
J David Curb
Jacques E Rossouw
Jamardan Khandekar
JoNell Potter
Norman Lasser
Rebecca J Rodabough
P304
P356
10.1016/J.MATURITAS.2006.05.004
P577
2006-07-11T00:00:00Z